Zuzanna Markiewicz-Sandowska
Warsaw, MZ 02781, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy.
Journal: bioRxiv : the preprint server for biology
Published: December 25, 2025
Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts.
Journal: International journal of molecular sciences
Published: December 04, 2025
Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 17, 2025
Sex- and mouse strain-related differences in body weight gain, composition of the gut microbiota, and levels of selected metabolites in response to a Western-style diet.
Journal: BMC gastroenterology
Published: May 20, 2025
Western Diet and fecal microbiota transplantation alter phenotypic, liver fatty acids, and gut metagenomics and metabolomics in Mtarc2 knockout mice.
Journal: Genes & nutrition
Published: February 17, 2025
Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D In Vitro Cultures.
Journal: Anticancer research
Published: May 31, 2024
Evidence supporting the oncogenic role of BAZ1B in colorectal cancer.
Journal: American journal of cancer research
Published: July 07, 2022
Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models.
Journal: International journal of molecular sciences
Published: August 17, 2021
Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer Models.
Journal: International journal of molecular sciences
Published: January 18, 2021
Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock.
Journal: European journal of medicinal chemistry
Published: September 11, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026